<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Causative genetic variants have to date been identified for only a small proportion of familial <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>While conditions such as <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">Familial Adenomatous Polyposis</z:e> and <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> have well defined genetic causes, the search for variants underlying the remainder of familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is plagued by <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The recent identification of families with a heritable predisposition to <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> arising through the serrated pathway (familial serrated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> or Jass syndrome) provides an opportunity to study a subset of familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in which <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> may be greatly reduced </plain></SENT>
<SENT sid="3" pm="."><plain>A genome-wide linkage screen was performed on a large family displaying a dominantly-inherited predisposition to serrated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> genotyped using the Affymetrix GeneChip Human Mapping 10 K SNP Array </plain></SENT>
<SENT sid="4" pm="."><plain>Parametric and nonparametric analyses were performed and resulting regions of interest, as well as previously reported <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility loci at 3q22, 7q31 and 9q22, were followed up by finemapping in 10 serrated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> families </plain></SENT>
<SENT sid="5" pm="."><plain>Genome-wide linkage analysis revealed regions of interest at 2p25.2-p25.1, 2q24.3-q37.1 and 8p21.2-q12.1 </plain></SENT>
<SENT sid="6" pm="."><plain>Finemapping linkage and haplotype analyses identified 2q32.2-q33.3 as the region most likely to harbour linkage, with <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> logarithm of the odds (HLOD) 2.09 and nonparametric linkage (NPL) score 2.36 (P = 0.004) </plain></SENT>
<SENT sid="7" pm="."><plain>Five primary candidate genes (CFLAR, CASP10, CASP8, FZD7 and BMPR2) were sequenced and no segregating variants identified </plain></SENT>
<SENT sid="8" pm="."><plain>There was no evidence of linkage to previously reported loci on chromosomes 3, 7 and 9 </plain></SENT>
</text></document>